MedTrace Logo

Radioactive Seed-guided Resection of Cholangiocellular Carcinoma in Cirrhotic Patients

NCT05989789 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2023-08-14

No results posted yet for this study

Summary

Detection of cholangiocellular and hepatocellular carcinomas can be challenging in both radiologic imaging and during surgical resection. Therefore, radioactive seed-guided resection of these tumors, analogously to breast cancer, could be an interesting approach. The investigators present two cases of cirrhotic patients where this method of tumor labelling was used.

Conditions

Interventions

DEVICE

Radioactive Seed Implantation

In patients where initially the tumour lesion could not be identified, a radioactive seed was implanted and intraoperatively detected with a geiger counter sonde.

Sponsors & Collaborators

  • Clarunis - Universitäres Bauchzentrum Basel

    lead OTHER

Principal Investigators

  • Savas D Soysal, Professor · Clarunis Basel

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-15
Primary Completion
2021-03-27
Completion
2021-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05989789 on ClinicalTrials.gov